Last reviewed · How we verify
NCT04189718
Comparative Evaluation of Osseodensification Versus Conventional Implant Site
NA trial testing osseodensification protocol in Bone Density in 22 participants. Completed in 30 October 2019.
15 October 2019
Quick facts
| Lead sponsor | Krishnadevaraya College of Dental Sciences & Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 30 November 2017 |
| Primary completion | 15 October 2019 |
| Estimated completion | 30 October 2019 |
| Sites | 1 location across India |
Drugs / interventions tested
- osseodensification protocol
- conventional implant site preparation protocol
Conditions studied
- Bone Density — all drugs for Bone Density →
- Implant Stability — all drugs for Implant Stability →
Sponsor
Krishnadevaraya College of Dental Sciences & Hospital
Who can join
Adults 18 to 75, any sex, with Bone Density or Implant Stability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study is a human, prospective, randomised controlled clinical trial conducted to explore and compare the clinical and radiological outcome of Osseodensification protocol with conventional implant site preparation protocol. The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04189718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bone Density
Currently open trials in the same condition.
- NCT07010146 — Role of Estrogen on Skeletal Outcomes in FHA · Phase 2 · recruiting
- NCT06903923 — Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy · Phase 2 · recruiting
- NCT06949280 — Metabolic Health, Bones and Nuts During Weight Loss in Adults · NA · recruiting
- NCT07031778 — Topic Simvastatin for Bone Regeneration · EARLY_PHASE1 · recruiting
- NCT06683222 — Mediating Role of Myokines in the Dialogue Between Muscle and Bone Tissue in a Population of Healthy Women Aged 20-89 Ye · NA · recruiting
Other Krishnadevaraya College of Dental Sciences & Hospital trials
Trials by the same sponsor.
- NCT06525285 — MCAF and EMD With and Without CTG Wall Technique for the Treatment of Class III and IV Gingival recessions-a Randomized · NA · recruiting
- NCT06541912 — Comparative Evaluation of Implant Stability, Soft & Hard Tissue Healing Around UV Activated vs Conventional Implants · NA · recruiting
- NCT06775392 — Comparative Evaluation of Bromelain-Quercetin Gel With Chlorhexidine Gel as Subgingival Local Drug Delivery Following Sc · Phase 1 · completed
- NCT06060119 — Comparison of Microneedling and CTG for Gingival Augmentation- A RCT · Phase 2 · unknown
- NCT06522321 — Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone · Phase 2 · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04189718 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Krishnadevaraya College of Dental Sciences & Hospital
- Last refreshed: 6 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04189718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing